News | News By Subject | News by Disease News By Date | Search News

Blood substitute News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Northfield Laboratories (NFLD) Terminates All of its Operational and Staff Employees and Shuts Down     5/11/2009
Northfield Laboratories (NFLD) Receives Complete Response Letter for PolyHeme BLA; Data Inadequate for Final Approval Action     5/1/2009
Northfield Laboratories (NFLD) Asks FDA for Quick PolyHeme Review     10/30/2008
Synthetic Blood International, Inc. (SYBD) Provides Updates On Phase II-B Clinical Trial Of Oxycyte; Additional Data Submitted End Of May     5/19/2008
Biopure Corporation (BPUR) Says UK Regulator Needs More Data on Blood Component     4/7/2008
Independent Data Safety Monitoring Board Recommends Continuation of Sangart, Inc.'s Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review     3/11/2008
Northfield Laboratories (NFLD) Blood Substitute Misses Phase 3 Trial Goals     5/23/2007
Positive Statistical Analysis from Synthetic Blood International, Inc. (SYBD)'s Oxycyte Traumatic Brain Injury Trial Indicates Achievement of Primary Endpoint     5/15/2007
Northfield Laboratories (NFLD) Blood Substitute Misses Trial Goal     12/20/2006
FDA Committee Recommends Against Biopure Corporation (BPUR) Phase III Study     12/15/2006
Inova Regional Trauma Center Halts Enrollment In Phase 3 PolyHeme Study; Northfield Laboratories (NFLD) Developed Blood-Substitute     7/28/2006
Northfield Laboratories (NFLD) Denies Any Coverup On Blood Trial; Shares Drop     2/24/2006

News from Around the Web
Women With Alzheimer's Worsen Twice As Fast As Men, Alzheimer's Association Study     7/22/2015
Fake 'Cells' Pave Way for Synthetic Blood, University of North Carolina Study     1/11/2011
Blood Substitute Found Safe in Large Phase III Trial at University of Maryland     6/23/2008
Use Of Hemoglobin-based Blood Substitutes Associated With Increased Risk Of Death, Heart Attack, National Institutes of Health (NIH) Study Shows; FDA Faulted for Approving Studies of Artificial Blood     4/29/2008
Acusphere Inc. (ACUS) Races to Get Product Released     10/30/2007
FDA: Blood Substitute Test Shouldn't Go On     12/15/2006
Officials To Re-Examine Studies Of Emergency Treatments     8/30/2006
FDA Avoids Law Violation By Canceling Secret Meeting On Experimental Blood Substitute     7/14/2006
FDA Is Sued Over Closed-Door Meeting     7/13/2006
Officials: Substitute Blood Study Unethical     3/14/2006
Ethicists Blast Study Testing Fake Blood     3/1/2006
Do-It-Yourself Blood Vessels     2/28/2005
Genetically Modified Fish Used To Make Human Protein     9/9/2004
Promising Inorganic Blood Substitute: Compound Produces Circulating "Microbubbles" That Pick Up And Deliver Oxygen     4/16/2004
Einstein Researchers Develop Blood Substitute That Shows Promise For Use In Emergency Situations     12/2/2003

Press Releases
Entegrion Lands Prototype Development Contract With The Navy     10/1/2008
Oxygen Biotherapeutics (OXBO) Provides Update on Recent Events and Phase IIb Oxycyte Clinical Trial     7/10/2008
Sangart, Inc. Completes Enrollment in Phase III Study of Its Novel Blood Substitute Hemospan     3/24/2008
HemoBioTech, Inc. Takes the Next Step to Facilitate Clinical Study in India of its Human Blood Substitute, Promotes Saraswathy Swaminathan to Manager of Foreign Clinical Affairs     7/17/2007
HemoBioTech, Inc. Engages CRO to Facilitate Clinical Study in India of Its Human Blood Substitute, HemoTech     6/21/2007
Hemobiotech, Inc. Chief Executive Officer Provides Year End Review And Addresses Global Strategy     12/28/2006
Sangart, Inc. Announces Publication Of Phase II Study Results In The Journal of the American Society Of Anesthesiologists - Anesthesiology     12/20/2006
Biopure Corporation (BPUR) Announces Next Steps For Navy's Proposed 'Resus' Trauma Trial Of Hemopure(R)     12/20/2006
Sanguine Corporation (SGNC) Meets With FDA To Define PHER-O2 Regulatory Path     12/6/2006
Northfield Laboratories (NFLD) Completes Enrollment In Pivotal Phase III PolyHeme(R) Trial; Top-line Data From Study Expected In Fall     8/1/2006
ProtoKinetix Inc. (PKTX.OB) Synthetic AFGP Dramatically Reduces Platelet Aggregation, Clumping At Various Temperatures     5/6/2005
Synthetic Blood International, Inc. (SYBD) Opens Clinical Site For Phase II Oxycyte Trial At Virginia Commonwealth University Medical Center     4/7/2005
Sangart, Inc. Completes Enrollment In Phase II Clinical Study Of Hemospan(R)     2/24/2005
Synthetic Blood International, Inc. (SYBD) Initiates First Phase II Oxycyte Trial     1/6/2005
Sanguine Corporation's (SGNC) PHER-O2 Successfully Completes Animal Safety And Efficacy Trials At The University of Alberta     11/17/2004